---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-110341"
form_type: "8-K"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:07:12.630535+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cypherpunk Technologies (fka Leap Therapeutics) enters up to $200M ATM equity sales agreement with Cantor Fitzgerald

## Summary
- Company entered into Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. to sell up to $200M of common stock.
- Cantor will receive a commission of up to 3.0% of gross proceeds from each sale.
- Sales will be made 'at the market' under existing shelf registration statement (File No. 333-278015).
- Company has no obligation to sell any shares and can suspend or terminate agreement at any time.

## SEC filing metadata
- accession: 0001104659-25-110341
- form_type: 8-K
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000110465925110341/0001104659-25-110341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000110465925110341/tm2530735d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-110341
- JSON: https://secwatch.observer/filing/0001104659-25-110341.json
- Plain text: https://secwatch.observer/filing/0001104659-25-110341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.